Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 5,030.00
-180.00 (-3.45%)
Jul 21, 2026, 3:30 PM KST
-68.76% (1Y)
| Market Cap | 60.46B -68.8% |
| Revenue (ttm) | 16.21B +87.1% |
| Net Income | -57.32B |
| EPS | -953.45 |
| Shares Out | 12.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 53,034 |
| Open | 5,210.00 |
| Previous Close | 5,210.00 |
| Day's Range | 4,945.00 - 5,310.00 |
| 52-Week Range | 4,950.00 - 16,480.00 |
| Beta | 0.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 18, 2026 |